Neogenomics Inc
NEO· Nasdaq
Filed May 10, 2016 · 10-Q · 40 days after period end · 0001564590-16-018998
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | $155.00K | -$761.00K | $102.00K | $3.00K |
| EPS Diluted | -$0.07 | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 10, 2016 · 40 d after period end